Structure-Guided Design of Peptide Inhibitors Targeting Class I Viral Fusion Proteins.

Gonepudi, Narendra Kumar et al.·Pathogens (Basel·2025·
RPEP-111442025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Structure-Guided Design of Peptide Inhibitors Targeting Class I Viral Fusion Proteins.
Published In:
Pathogens (Basel, Switzerland), 15(1) (2025)
Database ID:
RPEP-11144

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-11144·https://rethinkpeptides.com/research/RPEP-11144

APA

Gonepudi, Narendra Kumar; Baffour Awuah, Harry; Xu, Wang; Katte, Revansiddha H; Lu, Maolin. (2025). Structure-Guided Design of Peptide Inhibitors Targeting Class I Viral Fusion Proteins.. Pathogens (Basel, Switzerland), 15(1). https://doi.org/10.3390/pathogens15010032

MLA

Gonepudi, Narendra Kumar, et al. "Structure-Guided Design of Peptide Inhibitors Targeting Class I Viral Fusion Proteins.." Pathogens (Basel, 2025. https://doi.org/10.3390/pathogens15010032

RethinkPeptides

RethinkPeptides Research Database. "Structure-Guided Design of Peptide Inhibitors Targeting Clas..." RPEP-11144. Retrieved from https://rethinkpeptides.com/research/gonepudi-2025-structureguided-design-of-peptide

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.